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EnhanceWellness  (EW)  is  a  community-based  health 
promotion  program  that  helps  prevent  disabilities  and 
improves health and functioning in older adults. A previ-
ous randomized controlled trial demonstrated a decrease 
in inpatient use for EW participants but did not evaluate 
health care costs. We assessed the effect of EW participa-
tion on health care costs.
Methods
We  performed  a  retrospective  cohort  study  in  King 
County,  Washington.  Enrollees  in  Group  Health 
Cooperative  (GHC),  a  mixed-model  health  maintenance 
organization, who were aged 65 years or older and who 
participated in EW from 1998 through 2005 were matched 
1:3 by age and sex to GHC enrollees who did not participate 
in EW. We matched 218 EW participants by age and sex 
to 654 nonparticipants. Participants were evaluated for 1 
year after the date they began the program. The primary 
outcome was total health care costs; secondary outcomes 
were inpatient costs, primary care costs, percentage of hos-
pitalizations, and number of hospital days. We compared 
postintervention outcomes between EW participants and 
nonparticipants by using linear regression. Results were 
adjusted for prior year costs (or health care use), comorbid-
ity, and preventive health care-seeking behaviors.
Results
Mean age of participants and nonparticipants was 79 
years, and 72% of participants and nonparticipants were 
female. Adjusted total costs in the year following the index 
date were $582 lower among EW participants than non-
participants, but this difference was not significant.
Conclusion
Although  EW  participation  demonstrated  health  ben-
efits, participation does not appear to result in significant 
health  care  cost  savings  among  people  receiving  health 
care through a health maintenance organization.
Introduction
Several health promotion and disease prevention pro-
grams designed for older adults have been developed and 
evaluated for their health benefits and resource use (1-5). 
These programs focus on improving older adults’ general 
health and encouraging self-management of chronic medi-
cal  conditions.  Specific  aspects  of  health  improvement, 
such as improving mental well-being or increasing physi-
cal activity, are often the focus of health improvement and 
are pursued because of a client’s interest and motivation. 
These  programs  connect  clients  with  information  and 
resources that help them address their personal health 
concerns, build confidence in health care decision making, 
and increase physical activity. Such health promotion pro-
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grams for older adults improve health outcomes, and they 
have demonstrated decreased use of health care resources 
resulting from participation, which results in decreased 
health care costs (2,3). However, to our knowledge these 
studies used self-reported data rather than actual health 
care costs.
EnhanceWellness  (EW,  formerly  known  as  Health 
Enhancement Program, or HEP) targets older people at 
risk for functional decline. Nurses and social workers meet 
with  community-living  elders  to  help  increase  physical 
activity, promote social activity, improve mental health, 
and  enhance  self-management  of  chronic  conditions  to 
improve  health  and  functioning.  In  a  1998  randomized 
controlled trial, EW participants increased their physical 
activity, decreased their use of psychoactive medications, 
and  decreased  their  number  of  hospital  days  (2).  After 
that  study,  senior  centers  in  the  Seattle,  Washington, 
area  began  implementing  EW,  and  enrollees  of  Group 
Health  Cooperative  (GHC),  a  consumer-governed,  non-
profit health care system that provides both health care 
and  medical  coverage,  started  participating  in  the  pro-
gram. A follow-up study conducted in 2002 evaluated the 
program  as  it  operated  in  the  community,  outside  the 
controlled setting of a randomized trial (5). This study also 
demonstrated significant benefits, including a reduction 
in disability risk factors, improvement in health status, 
no decrease in functional status, and no increase in self-
reported health care use.
EW has been confused with the EnhanceFitness Program 
(EF) because of their similar names and the fact that both 
have been studied in a similar older adult population (6,7) 
However, the programs are distinct: EF is a group exercise 
program,  whereas  EW  is  a  comprehensive,  participant-
centered wellness program that includes a health assess-
ment,  a  tailored  health  plan,  and  motivational  support 
to achieve a self-chosen goal. EW participants, if desired, 
may include regular physical activity and join EF, a cov-
ered benefit for GHC members. Less than 10% of GHC 
members typically participate in both programs, although 
not necessarily simultaneously (M. Thompson, oral com-
munication, December 2008).
Although  health  benefits  and  a  reduction  in  hospital 
days have been demonstrated, EW’s effect on health care 
use and costs has not been previously analyzed. The avail-
ability of comprehensive cost and use data for GHC mem-
bers made studying these questions with GHC members 
who had participated in EW attractive. We hypothesized 
that participation in EW would lower overall health care 




EW  is  offered  at  community  centers,  many  of  which 
are  senior  centers,  located  in  the  greater  Puget  Sound 
region. Senior Services, a private nonprofit organization 
with  250  employees  established  in  1967,  operates  EW. 
Nearly all nurses and social workers in EW programs in 
King County are employed either by Senior Services or 
by the hosting EW sites. The main sources of funding for 
Senior Services for EW programs in King County are the 
Aging and Disability Services of Seattle and King County 
and the Public Health Department of Seattle and King 
County. Office space and supplies are often donated by 
hosting sites. Participants are asked to make a donation 
at the time of graduation but this amount covers only a 
small amount of actual EW costs. Senior Services estimat-
ed that the cost to administer EW at its King County sites 
in 2004 was $400 per participant per year. Although EW 
has been disseminated beyond King County, Washington, 
we restricted our study to King County, where GHC is 
based (8).
GHC is a consumer-governed, mixed-model health main-
tenance organization (HMO) with more than 500,000 mem-
bers in the Pacific Northwest; according to our research, 
approximately 65,000 members are aged 65 years or older, 
and 27,900 reside in King County. Health outcomes and 
cost data are available and complete for all GHC members, 
regardless of whether they receive their care at a GHC-
owned health care facility. GHC health care use and cost 
data have been studied and validated (9), and we used 
these data to capture our outcomes data. The institutional 
review boards of the University of Washington and GHC 
approved the study protocol.
Participants
We  chose  our  sample  from  GHC  members  who  were 
aged  65  years  or  older,  resided  in  King  County,  and 
voluntarily  participated  in  EW  from  March  15,  1998, 
through April 15, 2005. From this group, we selected par-VOLUME 7: NO. 2
MARCH 2010
  www.cdc.gov/pcd/issues/2010/mar/09_0003.htm • Centers for Disease Control and Prevention  3
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the US Department of Health and Human Services, the 
Public Health Service, the Centers for Disease Control and Prevention, or the authors’ affiliated institutions. Use of trade names is for identification only and 
does not imply endorsement by any of the groups named above.
ticipants who were continuously enrolled in GHC for at 
least 1 year before and 1 year after the first day of their 
EW enrollment. The date of EW enrollment (ie, the first 
day an EW participant signed a consent form, formally 
agreeing to participate in the program) was defined as 
the “index date.” We excluded enrollees who had been in 
a long-term–care facility during the year before the index 
date because of the high costs involved that would have 
skewed the overall results. 
Each EW participant was age- and sex-matched to 3 
GHC members who had not participated in EW (“non-
participants”). Nonparticipants were assigned an index 
date  that  corresponded  to  the  index  date  of  the  EW 
participant to whom they were matched, creating com-
parable  pre-index  and  postindex  enrollment  periods. 
Inclusion criteria for nonparticipants were identical to 
criteria for EW participants. Our analysis included com-
parisons between 218 EW participants and 654 matched 
nonparticipants.
Intervention
EW has been described in detail elsewhere (2,3). Briefly, 
after  EW  clients  complete  the  program’s  health  intake 
questionnaire, which assesses risk factors for functional 
decline,  they  meet  with  a  social  worker  or  nurse  for 
approximately  1  hour  to  discuss  personal  health  con-
cerns, review the findings of the questionnaire, and iden-
tify personal health goals. Clients develop strategies for 
improving health and make “health action plans.” They 
are encouraged, but not required, to seek out health and 
community  services  when  needed.  These  services  may 
include appointments with primary care providers, medi-
cal specialists, social services, or mental health services, 
or participation in an organized exercise program. Clients 
often need follow-up appointments with the nurse or social 
worker, either in person or by telephone. The recommend-
ed minimum time for program participation was 1 year 
until November 2003, at which point the recommended 
minimum time was reduced to 6 months.
Outcome measures
Total  health  care  costs  during  the  year  following  the 
index  date  was  the  primary  outcome  measure.  Total 
costs included inpatient, primary care, and nonprimary 
care outpatient costs. Nonprimary care outpatient costs 
consisted of outpatient specialty care, outpatient mental 
health, emergency department care, outpatient pharmacy, 
outpatient  laboratory,  outpatient  radiology,  long-term 
care, and drug and alcohol treatment costs. Secondary out-
comes were inpatient and primary care costs, percentage 
of hospitalizations, and number of hospital days. All cost 
data were captured from the GHC cost accounting system 
previously described (6,9).
Data analysis
Participation (yes/no) in EW was our main predictor of 
interest. We included age, sex, prior year health care costs 
or use (as appropriate), comorbidity, and tendency to use 
preventive services as covariates in our analyses because 
these factors typically influence health care use and costs. 
We  assessed  comorbidity  and  chronic  disease  burden 
by using the GHC diabetes and heart registries and the 
Charlson comorbidity index (10). We used the methods of 
the HMO Research Network, which based its index on the 
method outlined by Deyo et al (11), with the addition of 
peripheral vascular disorder procedure codes and outpa-
tient encounters as recommended (10,12,13) to determine 
our Charlson comorbidity index.
We assessed inclination to use preventive health ser-
vices  by  using  a  preventive  services  score,  which  takes 
into  account  preventive  health  services  and  preventive 
visits (14,15). This score is the sum of the number of times 
a study participant received colon cancer screening (fecal 
occult  blood  test  or  flexible  sigmoidoscopy),  a  screening 
mammogram,  prostate  cancer  screening,  an  influenza 
vaccine,  or  a  pneumococcal  vaccine  during  the  2  years 
immediately preceding the index date (score range, 0-8). If 
the person had none of the 4 services in the past 2 years, 
the preventive services score was the number of primary 
care preventive visits the person had in the past 2 years 
(maximum, 2).
Median household income and median education were 
available for analysis at the census block level for more 
80% of our participants. These socioeconomic status vari-
ables were considered but not included in the final model 
because their inclusion did not alter our results.
Statistical analysis
The primary analysis focused on differences in health 
care costs and use between EW participants and matched 
nonparticipants. We adjusted all costs to 2005 US dollars VOLUME 7: NO. 2
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by accessing the Medical Care component of the Consumer 
Price Index for the participant’s index year (16). We used 
2-tailed t tests and χ2 tests to compare demographic and 
health-related characteristics and unadjusted health care 
cost and use measures for participants and their matched 
comparisons.  We  used  ordinary  least  squares  linear 
regression to analyze cost differences, adjusting for covari-
ates; this modeling approach yields unbiased estimates of 
differences in mean costs when the sample size is large 
(17). Because the distribution of health care costs is often 
skewed, as many people have no costs and a few have high 
costs, we repeated our analysis by using log-transformed 
costs. All analyses were performed using Stata, version 9.0 
(StataCorp LP, College Station, Texas).
Results
Most EW participants (88%) spent 6 months or longer 
in  the  program;  approximately  50%  spent  12  or  more 
months, and 20% were in the program for more than 2 
years. EW participants were identical to nonparticipants 
in terms of average age (79 y) and sex (72% female) (Table 
1). We noted several significant differences between the 
groups,  including  a  larger  comorbidity  burden  among 
EW  participants,  as  measured  by  a  higher  Charlson 
comorbidity  index  and  a  larger  proportion  enrolled  in 
the GHC diabetes and heart disease registries. The pre-
ventive services score was significantly higher for EW 
participants, suggesting a stronger tendency to receive 
preventive services.
Total  costs,  inpatient  costs,  percentage  hospitalized, 
and number of hospital days were not significantly dif-
ferent  between  participants  and  nonparticipants,  either 
at baseline or in the year after the index date (Table 2). 
The only significant difference was in unadjusted primary 
care costs, which were higher by $325 in the EW group 
(P < .001) at baseline and $177 higher in the year after 
the index date (P = .04). After adjusting for age, sex, prior 
year total costs, preventive services score, Charlson comor-
bidity index, and presence on the GHC diabetes or heart 
disease registries, total health care costs in the year after 
the index date were $582 lower for EW participants than 
for nonparticipants, but this difference was not significant. 
The  results  were  unchanged  when  we  used  log-trans-
formed costs. There were no differences in inpatient use or 
primary care use between the 2 groups at baseline or the 
year after the index date.
Discussion
We  found  that,  compared  with  nonparticipants,  EW 
participants had nonsignificantly lower total health care 
costs and no difference in hospitalizations during the year 
following EW enrollment. This finding may have resulted 
from the fact that EW participants in our sample had a 
significantly larger comorbidity burden than did nonpar-
ticipants. Comorbidity is a major driver of hospital costs 
and total annual costs (18,19). Furthermore, the methods 
we used to adjust for comorbidity, although widely used, 
may not have allowed us to fully control for comorbidity 
differences between study groups (10,11,13)
Many  health  promotion  programs,  some  designed  for 
the  older  adult  population,  have  been  associated  with 
decreased health risks and decreased health care use (1-
3,20-23). Health promotion programs evaluated by Lorig 
et al and Holland et al most closely resemble the EW pro-
gram (3,4). These studies evaluated health outcomes and 
health care use, but neither assessed health care costs. 
Lorig et al found a significant decrease in hospitalizations 
and hospital days during their 6-month randomized con-
trolled trial. The average age in this study was 10 years 
younger than in ours, and the 2 study groups had balanced 
comorbidities. Conversely, Holland et al did not find a dif-
ference in health care use between study groups during 
their year-long randomized controlled trial of the Health 
Matters  Program  in  Sacramento,  California,  a  program 
modeled after EW (4,24). Similar to our analysis, the mean 
age of participants in Holland’s study was 73 years.
There are several differences between our analysis and 
the original randomized controlled trial that was used to 
evaluate EW (2). The original trial lasted 12 months, and 
outcomes were evaluated for the 12 months of program 
enrollment. After the original trial, EW evolved into a 6-
month program, so our analyses included EW participants 
with varying duration of program participation. For most 
EW participants, 6 months of EW participation confers 
favorable effects on disability risk factors (eg, depression, 
physical inactivity) that are comparable to 12 months of 
participation (25). However, such reductions in disability 
risk factors do not appear to translate into lower overall 
health care costs.
A strength of our analysis was that we reported actual 
health care costs. To our knowledge, no other analysis of 
a health-promotion, disability-prevention health resource VOLUME 7: NO. 2
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has used actual cost data. Health care use is often used 
as a proxy for costs, or alternatively, costs are estimated 
from claims data (1,22). Furthermore, our health care use 
data were derived from automated data sources, which are 
more accurate in assessing health care use and costs than 
are self-reported data (26,27).
Our  study  has  several  limitations.  Our  study  had 
an  observational  design,  which  can  result  in  residual 
confounding  and  selection  bias.  Residual  confounding 
in  relation  to  the  comorbidity  differences  we  observed 
between study groups is likely, although we attempted 
to adjust for them. Research published after our study 
ended demonstrated that total annual costs increase with 
increasing comorbidity and that 4 conditions — hyperten-
sion, depression, use of warfarin, and skin ulcers/cellulitis 
— should be added to the Charlson comorbidity index to 
accurately predict total annual costs (19). We used the 
preventive services score to address selection bias related 
to  the  potential  tendency  of  more  prevention-oriented 
people to participate in EW. This score has been used in 
prior research with GHC members but may not have fully 
accounted for this form of selection bias (14). We also con-
sidered using propensity scores to adjust for selection bias 
but  lacked  enough  covariates  to  independently  predict 
program participation.
Another limitation was a lack of detail on health care 
use. In particular, we could not distinguish increased use 
that  may  have  been  prompted  by  participation  in  EW 
(eg, more visits related to health problems identified by 
EW). Also, apart from EF, we had no information about 
exercise and other health promotion programs that EW 
participants may have pursued as a result of their partici-
pation in EW. Finally, our sample size of just over 200 EW 
participants may have been too small to detect meaningful 
cost differences given the large variances associated with 
health care cost and use data.
EW improves the health of older adults at risk for func-
tional decline (28). However, we did not find that overall 
health care costs were significantly reduced by EW pro-
gram participation.
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Tables






(N = 654) P Value
Mean age, y (SD) 78. (.8) 78. (.8) >.99
% Female 72. 72. >.99
Mean preventive services score (SD)a 3.0 (1.2) 2.8 (1.) .03
Mean Charlson comorbidity index (SD)b 1.0 (1.3) 0.7 (1.2) <.001
% Listed on GHC diabetes registry 20. 1.1 .02
% Listed on GHC heart disease registry 3.1 29.2 <.001
 
a Derived from the sum of the number of times a subject received colon cancer screening (fecal occult blood test or flexible sigmoidoscopy), a screening mam-
mogram, prostate cancer screening, an influenza vaccine, or a pneumococcal vaccine during the 2 years immediately preceding the index date (score range 
0-8; higher scores indicate receipt of more preventive services). 
b See Methods section for a description of this score. The mean Charlson comorbidity index and the percentage of participants listed on the Group Health 
Cooperative diabetes and heart disease registries were used to measure comorbidity and chronic disease burden. 
Table 2. Health Care Costs and Use of Participants and Nonparticipants at Baseline and Year Following Index Date,a Group 
Health Cooperative/EnhanceWellness Program, March 1998-April 2005 
Variable
Unadjusted Results Adjusted Results
Participants (N = 218) Nonparticipants (N = 654) Difference P Valueb Difference P Valueb
Cost, $c
Total
Baseline 7,07 ,207 80 .20
−582 .8
Year 1 8,091 7,977 11 .91
Inpatient
Baseline 773 1,11 −343 .29
−804 .22
Year 1 1,33 2,12 −828 .21
 
a The “index date” is date of enrollment (ie, the first day a participant signed a consent form, formally agreeing to participate in the program). 
b P values for unadjusted results derived from t tests; P values for adjusted results derived from linear regression (adjusted for age, sex, prior year costs, pre-
ventive services score, Charlson comorbidity index, and presence on the Group Health Cooperative diabetes or heart registries). 
c Results reported in mean 200 US dollars.
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Variable
Unadjusted Results Adjusted Results
Participants (N = 218) Nonparticipants (N = 654) Difference P Valueb Difference P Valueb
Primary care
Baseline 1,213 888 32 <.001
28 .72
Year 1 1,09 892 177 .0
Health care use
No. of hospital days
Baseline 0.3 0.0 0.03 .78
−0.15 .
Year 1 0.83 0.89 −0.06 .80
% Hospitalized
Baseline 10. 8. 2.0 .38
−0.02 .9
Year 1 13.3 13.3 0 >.99
 
a The “index date” is date of enrollment (ie, the first day a participant signed a consent form, formally agreeing to participate in the program). 
b P values for unadjusted results derived from t tests; P values for adjusted results derived from linear regression (adjusted for age, sex, prior year costs, pre-
ventive services score, Charlson comorbidity index, and presence on the Group Health Cooperative diabetes or heart registries). 
c Results reported in mean 200 US dollars.
Table 2. (continued) Health Care Costs and Use of Participants and Nonparticipants at Baseline and Year Following Index 
Date,a Group Health Cooperative/EnhanceWellness Program, March 1998-April 2005 